Stem Cells

You Asked, We Answered: Common Questions about Mesenchymal Stromal Cell Therapy

Get science-backed answers to the most commonly asked questions about the future of stem cell therapy in veterinary medicine.

1 CE Credit

Start Course

Rebecca Windsor

DVM, DACVIM (Neurology)

Vice President of Veterinary Affairs at Gallant

About the Course

In this session, we address your most common questions in this Q&A-based webinar covering what mesenchymal stromal cells (MSCs) are, their mechanisms of action, and their favorable safety profile. During the discussion, we explore how MSC therapies differ from traditional medications and how they can work synergistically with standard treatments by targeting the root cause of disease. We also review practical administration, along with the potential safety and efficacy of Gallant’s IV MSC therapy for refractory stomatitis in cats.

This program has been RACE approved (20-1354521) for 1 hour of continuing education credit for veterinarians and veterinary technicians/technologists in jurisdictions that recognize RACE approval.

Learning objectives

Understand the types of stem cells and how sourcing from different donors and tissues affects stem cell number, quality, and function
Explore the current data regarding the low risk for immune reaction and tumor formation when sourcing from healthy donors
Learn how IV stem cells have been demonstrated to reach target tissues
Understand the general mechanisms of action of stem cell therapy, most notably their immunomodulatory and paracrine effects

Start Learning Now

Explore courses, grow your skills, and earn CE credits - all at your pace.

What our learners say about
growing their skills and reaching new goals.

Leave a Review

About the presenter

Rebecca Windsor

DVM, DACVIM (Neurology)

Vice President of Veterinary Affairs at Gallant

Dr. Rebecca Windsor, DVM, DACVIM (Neurology), earned her veterinary degree from the University of California, Davis, in 2005. She completed a small animal medicine and surgery internship at North Carolina State University (2005–2006) and a residency in neurology and neurosurgery at UC Davis (2006–2009), achieving board certification through the American College of Veterinary Internal Medicine in 2009.

Dr. Windsor has extensive experience working in private specialty hospitals in the Washington, D.C. area, the San Francisco Bay Area, and Chicago. Most recently, she served as Chief of the Neurology Department and Neurology Internship Coordinator at Wheat Ridge Animal Hospital in Colorado. In 2024, she was honored as a “Best in Colorado Top Doctor” for excellence in veterinary medicine.

Deeply passionate about clinical research and education, Dr. Windsor has authored numerous publications and has been a Clinician Scientist with Ethos Discovery, a nonprofit scientific incubator, since 2021. She currently leads Ethos Discovery’s neurology research portfolio, focusing on immune-mediated neuroinflammatory diseases, particularly early detection and treatment strategies for necrotizing meningoencephalitis in dogs. In 2024, she was appointed the Ethos Discovery House Officer Research Project Coordinator, and she currently mentors over 100 veterinary interns and residents in clinical research.

In 2025, Dr. Windsor joined Gallant as Director of Veterinary Affairs, where she is dedicated to advancing veterinary medicine and educating the veterinary community on the therapeutic potential of stem cell therapy.